Cargando…
Aberrant Glycosylation as Immune Therapeutic Targets for Solid Tumors
SIMPLE SUMMARY: Glycosylation is one of the most pivotal post-translational modifications on all types of biomolecules for the formation of glycoproteins, glycolipids, and glycoRNAs in a tissue-type specific manner. Normal glycans participate in biological events such as development, metabolism, dif...
Autores principales: | Matsumoto, Yasuyuki, Ju, Tongzhong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10377354/ https://www.ncbi.nlm.nih.gov/pubmed/37509200 http://dx.doi.org/10.3390/cancers15143536 |
Ejemplares similares
-
Epigenetic Bases of Aberrant Glycosylation in Cancer
por: Dall’Olio, Fabio, et al.
Publicado: (2017) -
Morphology of Biomaterials Affect O-Glycosylation of HUVECs
por: Hu, Xingyou, et al.
Publicado: (2022) -
Involvement of Aberrant Glycosylation in Thyroid Cancer
por: Miyoshi, Eiji, et al.
Publicado: (2010) -
Therapeutic Monoclonal Antibodies Targeting Immune Checkpoints for the Treatment of Solid Tumors
por: Gravbrot, Nicholas, et al.
Publicado: (2019) -
Aberrant glycosylation associated with enzymes as cancer biomarkers
por: Meany, Danni L, et al.
Publicado: (2011)